Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Wu, Li-Tzy (2010)
Publisher: Dove Medical Press
Journal: Substance Abuse and Rehabilitation
Languages: English
Types: Article
Subjects: rehabilitation, RA1-1270, Public aspects of medicine, global burden of disease, substance use disorders, substance abuse, Commentary, Substance Abuse and Rehabilitation
Li-Tzy Wu*Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Duke University Medical Center, Durham, NC, USA *Li-Tzy Wu is the Editor-in-Chief of Substance Abuse and RehabilitationAbstract: Alcohol, tobacco, and illegal drug use are pervasive throughout the world. Substance use problems are among the major contributors to the global disease burden, which includes disability and mortality. The benefits of treatment far outweigh the economic costs. Despite the availability of treatment services, however, the vast majority of people with substance use disorders do not seek or use treatment. Barriers to and unmet need for evidence-based treatment are widespread even in the United States. Women, adolescents, and young adults are especially vulnerable to adverse effects from substance abuse, but they face additional barriers to getting evidence-based treatment or other social/medical services. Substance use behaviors and the diseases attributable to substance use problems are preventable and modifiable. Yet the ever-changing patterns of substance use and associated problems require combined research and policy-making efforts from all parts of the world to establish a viable knowledge base to inform for prevention, risk-reduction intervention, effective use of evidence-based treatment, and rehabilitation for long-term recovery. The new international, open-access, peer-reviewed Substance Abuse and Rehabilitation (SAR) journal strives to provide an effective platform for sharing ideas for solutions and disseminating research findings globally. Substance use behaviors and problems have no boundaries. The journal welcomes papers from all regions of the world that address any aspect of substance use, abuse/dependence, intervention, treatment, and policy. The “open-access” journal makes cutting edge knowledge freely available to practitioners and researchers worldwide, and this is particularly important for addressing the global disease burden attributable to substance abuse.Keywords: global burden of disease, rehabilitation, substance abuse, substance use disorders
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Brick J. Handbook of the Medical Consequences of Alcohol and Drug Abuse. New York: The Haworth Press; 2004.
    • 2. Degenhardt L, Chiu WT, Sampson N, et al. Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Med. 2008;5(7):e141.
    • 3. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2010. New York: United Nations; 2010. http://www.unodc.org/ unodc/en/data-and-analysis/WDR-2010.html. Accessed 2010 Sep 27.
    • 4. Reference Group to the United Nations on HIV and Injecting Drug Use. The Global Epidemiology of Methamphetamine Injection: A Review of the Evidence on Use and Associations with HIV and Other Harm. Sydney, Australia: National Drug and Alcohol Research Centre, University of New South Wales; 2007.
    • 5. Hernandez SH, Nelson LS. Prescription drug abuse: insight into the epidemic. Clin Pharmacol Ther. 2010;88(3):307-317.
    • 6. Wu LT, Pilowsky DJ, Patkar AA. Non-prescribed use of pain relievers among adolescents in the United States. Drug Alcohol Depend. 2008;94(1-3):1-11.
    • 7. WHO International Consortium in Psychiatric Epidemiology. Crossnational comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ. 2000;78(4):413-426.
    • 8. Rose JE. Stress alleviation and reward enhancement: two promising targets for relapse prevention. Biol Psychiatry. 2010;68(8):687-688.
    • 9. Weiss F. Neurobiology of craving, conditioned reward and relapse. Curr Opin Pharmacol. 2005;5(1):9-19.
    • 10. World Health Organization. The facts about smoking and health. http://www.wpro.who.int/media_centre/fact_sheets/fs_20060530.htm. Accessed 2010 Sep 27.
    • 11. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2004;61(11):1107-1115.
    • 12. de Leon J, BecoƱa E, Gurpegui M, Gonzalez-Pinto A, Diaz FJ. The association between high nicotine dependence and severe mental illness may be consistent across countries. J Clin Psychiatry. 2002;63(9):812-816.
    • 13. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry. 1998;55(2):161-166.
    • 14. Wu LT, Anthony JC. Tobacco smoking and depressed mood in late childhood and early adolescence. Am J Public Health. 1999;89(12):1837-1840.
    • 15. World Health Organization. WHO Report on Global Tobacco Epidemic, 2009: implementing smoke-free environments. Geneva, Switzerland: World Health Organization; 2009. http://www.who.int/tobacco/ mpower/2009/gtcr_download/en/index.html. Accessed 2010 Sep 27.
    • 16. Harwood H. Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data. Bethesda, MD: The Lewin Group for the National Institute on Alcohol Abuse and Alcoholism; 2000.
    • 17. Mark TL, Woody GE, Juday T, Kleber HD. The economic costs of heroin addiction in the United States. Drug Alcohol Depend. 2001;61(2):195-206.
    • 18. World Health Organization. Women and Drug Abuse: The Problems in India. Geneva, Switzerland: World Health Organization; 2002.
    • 19. Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339-355.
    • 20. Greenefild SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1-21.
    • 21. Smith BD, Marsh JC. Client-service matching in substance abuse treatment for women with children. J Subst Abuse Treat. 2002;22(3):161-168.
    • 22. Ashley OS, Marsden ME, Brady TM. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse. 2003;29(1):19-53.
    • 23. World Health Organization. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: World Health Organization; 2009. http://www.who.int/healthinfo/ global_burden_disease/GlobalHealthRisks_report_full.pdf. Accessed 2010 Sep 27.
    • 24. World Health Organization. The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization; 2008. http://www. who.int/healthinfo/global_burden_disease/2004_report_update/en/ index.html. Accessed 2010 Sep 27.
    • 25. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.
    • 26. Center for Substance Abuse Treatment. Cost offset of treatment services. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2009. https://www.samhsa-gpra.samhsa.gov/CSAT/ view/docs/SAIS_GPRA_CostOffsetSubstanceAbuse.pdf. Accessed 2010 Sep 27.
    • 27. Wu LT, Kouzis AC, Leaf PJ. Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the National Comorbidity Survey. Am J Psychiatry. 1999;156(8):1230-1236.
    • 28. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640.
    • 29. Wu LT, Ringwalt CL. Use of alcohol treatment and mental health services among adolescents with alcohol use disorders. Psychiatr Serv. 2006;57(1):84-92.
    • 30. Wu LT, Pilowsky DJ, Schlenger WE, Hasin D. Alcohol use disorders and the use of treatment services among college-age young adults. Psychiatr Serv. 2007;58(2):192-200.
    • 31. Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF. Altered white matter microstructure in adolescent substance users. Psychiatry Res. 2009;173(3):228-237.
    • 32. National Institute on Drug Abuse. Drugs, brains, and behavior: the science of addiction. NIH Pub No. 07-5605. Bethesda, MD: National Institute on Drug Abuse, National Institutes of Health, US Department of Health and Human Services; 2007.
    • 33. Wu LT, Ringwalt CL. Alcohol dependence and use of treatment services among women in the community. Am J Psychiatry. 2004; 161(10):1790-1797.
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.

Share - Bookmark

Funded by projects

  • NIH | Evolution of Psychopatholog...
  • NIH | MDMA and Other Hallucinogen...
  • NIH | Classification of Substance...
  • NIH | Epdemiology of Non-Medical ...

Cite this article